Vaccines, blood, antisera, toxins and cultures in   Turkey

Exports In 2022, Turkey exported $553M in Vaccines, blood, antisera, toxins and cultures, making it the 25th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 119th most exported product in Turkey. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Turkey are: South Korea ($429M), Hungary ($43.7M), Germany ($14.5M), Iran ($8.57M), and Azerbaijan ($8.03M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Turkey between 2021 and 2022 were South Korea ($70.7M), Hungary ($43M), and Pakistan ($4.92M).

Imports In 2022, Turkey imported $2.25B in Vaccines, blood, antisera, toxins and cultures, becoming the 21st largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 22nd most imported product in Turkey. Turkey imports Vaccines, blood, antisera, toxins and cultures primarily from: South Korea ($498M), Germany ($405M), Switzerland ($273M), United States ($213M), and Ireland ($176M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Turkey between 2021 and 2022 were South Korea ($150M), United Kingdom ($34.1M), and Singapore ($33.5M).